National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Genocea Biosciences is a biotechnology & medical research business based in the US. Genocea Biosciences stocks (GNCA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.33 – the same closing value as a week prior. Genocea Biosciences employs 74 staff and has a trailing 12-month revenue of around $1.9 million.
National Bank Direct Brokerage
Interactive Brokers
Latest market close | $0.00 |
---|---|
52-week range | $0.00 - $0.02 |
50-day moving average | $0.00 |
200-day moving average | $0.11 |
Wall St. target price | $3.08 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.53 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $0.0002 from 2023-02-24
1 week (2023-05-23) | N/A |
---|---|
1 month (2023-04-29) | N/A |
3 months (2023-02-27) | N/A |
6 months (2022-12-02) | -97.30% |
1 year (2022-06-01) | -99.67% |
---|---|
2 years (2021-05-30) | N/A |
3 years (2020-06-03) | 2.61 |
5 years (2018-06-01) | 0.9429 |
Revenue TTM | $1.9 million |
---|---|
Gross profit TTM | $1.6 million |
Return on assets TTM | -57.59% |
Return on equity TTM | -525.78% |
Profit margin | 0% |
Book value | $0.21 |
Market capitalisation | $5,878 |
TTM: trailing 12 months
We're not expecting Genocea Biosciences to pay a dividend over the next 12 months.
Genocea Biosciences's shares were split on a 1:8 basis on 21 May 2019. So if you had owned 8 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Genocea Biosciences shares – just the quantity. However, indirectly, the new 700% higher share price could have impacted the market appetite for Genocea Biosciences shares which in turn could have impacted Genocea Biosciences's share price.
Over the last 12 months, Genocea Biosciences's shares have ranged in value from as little as $0.0001 up to $0.0235. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genocea Biosciences's is 1.6038. This would suggest that Genocea Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genocea Biosciences, Inc. , a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…The best stock trading app for beginners is easy to use and offers free trades.
Read more…Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
This guide provides step-by-step instructions on how to buy Coinbase Wrapped Staked ETH, lists some exchanges where you can get it and provides daily price data on (CBETH).